Homologous mutations near the junction of the sixth transmembrane domain and the third extracellular loop lead to constitutive activity and enhanced agonist affinity at all muscarinic receptor subtypes.
Previous studies have found that a mutation near the junction of the sixth transmembrane domain (TM6) and the third extracellular loop of the M5 muscarinic receptor leads to constitutive activation and enhanced agonist affinity for the mutated receptor. These results were consistent with the extended ternary complex model, which predicts a correlation between agonist affinity and constitutive activity. We have introduced the homologous mutation into all five subtypes of the highly conserved muscarinic receptor family; SerThr-->TyrPro was introduced into M1 and M5, and AsnThr-->TyrPro was introduced into M2, M3, and M4. In binding assays, these mutations produced increases in affinities toward acetylcholine and carbachol that ranged from 5-fold at the M2 receptor to 15- to 20-fold at M1, M3, and M4, to 40-fold at M5. In functional assays, all five mutant receptors exhibited constitutive activity, at levels ranging between 30 and 80% of the maximal response elicited by carbachol. In every case, the muscarinic antagonist atropine inhibited this constitutive activity with high affinity. Thus, despite differences in effector coupling and in wild-type sequence at the mutation site, all five subtypes were activated by this mutation at the top of TM6. Previous studies of the M5 subtype have indicated that TM6 is a ligand-dependent switch that sets the activation state of the receptor. Based on the results of the present study, it is possible that TM6 represents a general switch for the activation of the muscarinic receptor family.
Ford
Diane J
DJ
Department of Pharmacology, the Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA.
Essex
Anthony
A
Spalding
Tracy A
TA
Burstein
Ethan S
ES
Ellis
John
J
D016475:3T3 Cells; D000109:Acetylcholine / Q000378:metabolism; D000465:Algorithms; D000595:Amino Acid Sequence; D019943:Amino Acid Substitution; D000818:Animals; D002462:Cell Membrane / Q000378:metabolism; D005110:Extracellular Space / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D008969:Molecular Sequence Data; D018721:Muscarinic Agonists / Q000378:metabolism / Q000494:pharmacology*; D016296:Mutagenesis; D009154:Mutation / Q000235:genetics*; D011976:Receptors, Muscarinic / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism
D018721:Muscarinic Agonists; D011976:Receptors, Muscarinic; D000109:Acetylcholine